2018 American Transplant Congress

Tuesday, June 5, 2018

6:00pm-7:00pm

Early versus Late Cytomegalovirus Prophylaxis after Kidney Transplant

M. Harris, J. Byrns, J. Gommer, M. Laub, M. Ellis.

Poster Session D: Kidney Infectious  •  Hall 4EF

6:00pm-7:00pm

Effect of Belatacept on Late Acute Rejection Episodes and Graft Loss in Young Adults between the Ages of 18-24 Years: Post-Hoc Analysis of BENEFIT Study

A. Moudgil.

Poster Session D: Late Breaking  •  Hall 4EF

6:00pm-7:00pm

Effect of Conversion to CTLA4Ig Treatment on Tacrolimus-Induced Diabetic Rats

J. Il,¹ L. Jin,¹ K. Luo,¹ S. Lim,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 C. Yang.^1,2

Poster Session D: Immunosuppression Preclinical Studies  •  Hall 4EF

6:00pm-7:00pm

Effect of Direct-Acting Hepatitis C Treatment Regimens on Calcineurin Inhibitors in Liver and Kidney Transplant Patients

M. Laub, J. Byrns, M. Harris, C. Berg, S. Sanoff.

Poster Session D: Liver: Viral Hepatitis  •  Hall 4EF

6:00pm-7:00pm

Effects of Preformed Antibody on Survival Following Pig-to-Primate Liver Xenotransplantation

N. Louras, M. Patel, J. Shah, A. Andrews, Z. Wang, D. Sachs, P. Vagefi.

Poster Session D: B-cell / Antibody  •  Hall 4EF

6:00pm-7:00pm

Efficacy of Generic Sofosbuvir and Branded Daclatasvir Compared to Sofosbuvir and Ledipasvir Combination in the Treatment of Genotype 4 Hepatitis C Virus

H. Joharji, A. Al-Jedai, D. Alkortas, A. Ajlan, E. Devol, M. Ahmed, F. Aba Al-Khail, H. El-Siesy, M. Al-Sebayel, H. Al-Ashgar, M. Al-Quaiz, W. Alhomodi, A. Aloubal, A. Almohishir.

Poster Session D: Liver: Viral Hepatitis  •  Hall 4EF

6:00pm-7:00pm

Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient

P. Brown, D. Venkat.

Poster Session D: Kidney Infectious  •  Hall 4EF

6:00pm-7:00pm

Elevated Donor Terminal Creatinine Does Not Appear to Be Associated with Worse Outcomes in Kidney Transplantation

S. Rayhill, J. Haldorson.

Poster Session D: Kidney Donor Selection / Management Issues  •  Hall 4EF

6:00pm-7:00pm

End Stage Kidney Disease Risk Profile in Living Kidney Donors for Pediatric versus Adult Kidney Transplant Recipients in Australia and New Zealand

D. Lee,^1,2 J. Whitlam,² N. Cook,² A. Walker,³ F. Ierino,⁴ M. Roberts,¹ J. Kausman.³

Poster Session D: Kidney Living Donor: Selection  •  Hall 4EF

6:00pm-7:00pm

Enhancement of Muscle Regeneration and Function via Transplantation of Human Dystrophin Expressing Chimeric Cells as a Novel Myoblast Stem-Cell Based Therapy

M. Siemionow,¹ J. Cwykiel,¹ E. Marchese,¹ G. Rafidi,¹ K. Futoma,¹ A. Heydemann,² J. Garcia-Martinez,² E. Szilagyi.¹

Poster Session D: Stem Cell, Cellular Therapies and Regenerative Medicine  •  Hall 4EF